Chongqing Lummy Pharmaceutical (SZSE:300006) Total Long-Term Liabilities : ¥145.2 Mil (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Chongqing Lummy Pharmaceutical's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥145.2 Mil.

Chongqing Lummy Pharmaceutical Total Long-Term Liabilities Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Total Long-Term Liabilities Chart

Chongqing Lummy Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

220.92

47.84

169.08

206.44

170.86

Chongqing Lummy Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial															168.13	111.76	147.37	170.86	145.23

Chongqing Lummy Pharmaceutical Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Chongqing Lummy Pharmaceutical Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Lummy Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Yuma Road, Nan'an District, chongqing, CHN, 401123

Website

http://www.cqlummy.com

Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.

Executives

Lai Wen	Executives
Yuan Yuan	Supervisors
Qiu Yu	Directors, executives
Leng Xue Feng	Secretary, Director
Zhang Xiao Xue	Supervisors
Wang Ying	Director
Zhou Xue Mei	Supervisors
Zhao Bin	Executives
Tang Xiao Hai	Executives
Fu Rong	Executives
Li Xian Feng	Supervisors
Qiu Wei	Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines